145 related articles for article (PubMed ID: 10541167)
1. Angiogenesis and vascular growth factor receptor expression in malignant melanoma.
Lin EY; Piepkorn M; Garcia R; Byrd D; Tsou R; Isik FF
Plast Reconstr Surg; 1999 Nov; 104(6):1666-74. PubMed ID: 10541167
[TBL] [Abstract][Full Text] [Related]
2. Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique.
Takahashi A; Sasaki H; Kim SJ; Kakizoe T; Miyao N; Sugimura T; Terada M; Tsukamoto T
Biochem Biophys Res Commun; 1999 Apr; 257(3):855-9. PubMed ID: 10208873
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
[TBL] [Abstract][Full Text] [Related]
4. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
5. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
[TBL] [Abstract][Full Text] [Related]
6. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas.
Kaipainen A; Vlaykova T; Hatva E; Böhling T; Jekunen A; Pyrhönen S; Alitalo K
Cancer Res; 1994 Dec; 54(24):6571-7. PubMed ID: 7987857
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive dynamic fluorescence imaging of human melanomas reveals that targeted inhibition of bFGF or FGFR-1 in melanoma cells blocks tumor growth by apoptosis.
Valesky M; Spang AJ; Fisher GW; Farkas DL; Becker D
Mol Med; 2002 Feb; 8(2):103-12. PubMed ID: 12080186
[TBL] [Abstract][Full Text] [Related]
10. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression.
Kanellis J; Paizis K; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
Kidney Int; 2002 May; 61(5):1696-706. PubMed ID: 11967019
[TBL] [Abstract][Full Text] [Related]
11. Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells.
Herold-Mende C; Steiner HH; Andl T; Riede D; Buttler A; Reisser C; Fusenig NE; Mueller MM
Lab Invest; 1999 Dec; 79(12):1573-82. PubMed ID: 10616207
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor and its receptors during lung carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine in rats.
Takahama M; Tsutsumi M; Tsujiuchi T; Kido A; Sakitani H; Iki K; Taniguchi S; Kitamura S; Konishi Y
Mol Carcinog; 1999 Apr; 24(4):287-93. PubMed ID: 10326865
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
[TBL] [Abstract][Full Text] [Related]
14. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Steiner GE; Rockwell P; Gedlicka C; Burian M
Laryngoscope; 2001 Oct; 111(10):1834-41. PubMed ID: 11801954
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
17. Endothelial growth factor receptors in human fetal heart.
Partanen TA; Makinen T; Arola J; Suda T; Weich HA; Alitalo K
Circulation; 1999 Aug; 100(6):583-6. PubMed ID: 10441093
[TBL] [Abstract][Full Text] [Related]
18. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
Brychtova S; Bezdekova M; Brychta T; Tichy M
Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
[TBL] [Abstract][Full Text] [Related]
19. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.
Straume O; Akslen LA
Am J Pathol; 2002 Mar; 160(3):1009-19. PubMed ID: 11891198
[TBL] [Abstract][Full Text] [Related]
20. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle.
Möller B; Rasmussen C; Lindblom B; Olovsson M
Mol Hum Reprod; 2001 Jan; 7(1):65-72. PubMed ID: 11134362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
